Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,507,177
+$2,369,734 QoQ
Shares Held
20,288
+29.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#253
of 844 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SIT INVESTMENT ASSOCIATES INC holds $31,339,154 across 6 Diagnostics & Research names. NTRA ranks #3 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,965 | $12,516,452 | |
| 2 | A |
Agilent Technologies, Inc.
|
65,737 | $8,731,845 | |
| 3 | NTRA |
Natera, Inc.
This page
|
20,288 | $5,507,177 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,350 | $2,290,014 | |
| 5 | DGX |
Quest Diagnostics Inc
|
10,680 | $2,263,626 | |
| 6 | RVTY |
Revvity, Inc.
|
270 | $30,040 |
All Filings in NTRA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,507,177 | 20,288 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,137,443 | 15,688 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,593,963 | 15,688 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,073,722 | 19,095 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,225,909 | 19,095 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,700,223 | 19,095 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,741,756 | 17,320 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,198,774 | 17,320 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,616,769 | 14,930 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,390,192 | 15,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $197,316 | 3,150 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||